ANI Pharmaceuticals Stock Down 25% On Quarterly Results

Shares of ANI Pharmaceuticals, Inc. (ANIP) slipped nearly 25% on Tuesday morning after the company's fourth-quarter adjusted earnings missed Street estimates.

ANIP is currently trading at $26.87, down $8.79 or 24.65%, on the Nasdaq.

Net loss for the fourth quarter was $24.1 million or $1.72 per share, compared to a net loss of $3.6 million or $0.30 per share last year.

Adjusted earnings per share was $0.54 in the fourth quarter of 2021 compared to $0.80 in the fourth quarter of 2020. Analysts polled by Thomson Reuters expected earnings of $0.74 per share for the quarter. Analysts' estimates typically exclude one-time items.

Revenues for the fourth quarter rose to $60.9 million from $57.3 million last year. Analysts had a consensus revenue estimate of $56.3 million for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Follow RTT